{"id":"W4311917936","doi":"10.1016/j.annonc.2022.12.004","title":"Methodological and reporting standards for quality-of-life data eligible for European Society for Medical Oncology-Magnitude of Clinical Benefit Scale (ESMO-MCBS) credit","year":2022,"lang":"en","type":"article","venue":"Annals of Oncology","topic":"Economic and Financial Impacts of Cancer","field":"Economics, Econometrics and Finance","cited_by":36,"is_retracted":false,"has_abstract":true,"ca_institutions":"Queen's University","funders":"Genentech; Ipsen; European Society for Medical Oncology; Chugai Pharmaceutical; Seagen; Regeneron Pharmaceuticals; Servier; G1 Therapeutics; Amgen; Pfizer; World Health Organization; Radius Health; AstraZeneca; Eli Lilly and Company","keywords":"Medicine; Checklist; Quality of life (healthcare); Clinical trial; Clinical endpoint; Scale (ratio); Test (biology); Medical physics; Intensive care medicine; Internal medicine; Nursing","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":["metaresearch"],"consensus_categories":["metaresearch"],"category_scores_codex":[0.6451703,0.003333255,0.009323943,0.03108642,0.005477118,0.01162673,0.009599541,0.01138166,0.02635685],"category_scores_gemma":[0.8297646,0.003821333,0.01896308,0.0254147,0.01014445,0.005976853,0.01112295,0.01526143,0.008791612],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.01142067,"about_ca_system_score_gemma":0.04186356,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.002783028,"about_ca_topic_score_gemma":0.002506817,"domain_scores_codex":[0.186806,0.4515834,0.2957413,0.01315887,0.04783033,0.00488016],"domain_scores_gemma":[0.1115853,0.4746052,0.1102663,0.1449185,0.1530028,0.005621855],"domain_codex":"methods","domain_gemma":"reporting","domain_candidate":"reporting","domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.01154631,0.001872368,0.02847197,0.2148656,0.005622519,0.0009242513,0.01997153,0.005034301,0.003983729,0.09271453,0.2715393,0.3434536],"study_design_scores_gemma":[0.01139783,0.002387391,0.05276701,0.2119845,0.002799169,0.0009921034,0.006772662,0.01075034,0.006114615,0.08036898,0.6126269,0.001038526],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"protocol","genre_gemma":"methods","genre_scores_codex":[0.005993689,0.004911205,0.1466066,0.0072973,0.006469789,0.7887559,0.02868844,0.001170742,0.01010629],"genre_scores_gemma":[0.01062934,0.0008211049,0.108865,0.001760021,0.0003549985,0.8707135,0.005849318,0.0002765977,0.0007301293],"genre_candidate":"methods","genre_consensus":null,"teacher_disagreement_score":0.3548297,"threshold_uncertainty_score":0.4375682,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.7311834190191645,"score_gpt":0.5746809436174326,"score_spread":0.1565024754017319,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}